Opsona

About:

Opsona validates and develops new drug candidates and strategies that modulate innate immune systems.

Top Investors: Baxter International, Enterprise Ireland, Omnes Capital, Novartis Venture Fund, Amgen Ventures

Description:

Drug development firm focused on immunology. They are headquartered in Dublin, Ireland. Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways. Since its founding in 2004, Opsona has validated and developed a series of exciting new drug candidates and strategies which modulate the human innate immune system. We are located in Dublin, Ireland.

Total Funding Amount:

$81.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2004-01-01

Contact Email:

info(AT)opsona.com

Founders:

Luke O'Neill, Mark Heffernan

Number of Employees:

11-50

Last Funding Date:

2013-10-02

IPO Status:

Private

Industries: